As a result of the significant disruption that is being caused by the COVID-19 pandemic we are very aware that many researchers will have difficulty in meeting the timelines associated with our peer review process during normal times. Please do let us know if you need additional time. Our systems will continue to remind you of the original timelines but we intend to be highly flexible at this time.
Viral Emerging and Re-emerging Infectious Diseases
We invite authors to submit original research and review articles that focus on or illuminate aspects of the epidemiology, clinical, diagnostics, therapeutics and prevention of viral emerging and Re-emerging infectious diseases.
Currently open for submissions
Guest Editor - Alfonso J. Rodriguez-Morales
Spatial inequality, infectious diseases and disease control
We invite authors to submit original research and review articles that focus on emerging infectious diseases in humans and animals and brings together research that investigates the relationship between spatial inequalities and the impact and prevalence of infectious diseases.
The Erratum to this article has been published in Annals of Clinical Microbiology and Antimicrobials 2009 8:31
Annals of Clinical Microbiology and Antimicrobials considers good quality, novel and international research of more than regional relevance.
Research must include epidemiological and/or clinical information about isolates, and the journal covers the clinical microbiology of bacteria, viruses and fungi, as well as antimicrobial treatment of infectious diseases.
Hakan Leblebicioglu, Editor-in-Chief
Professor Leblebicioglu is the former head of the Department of Infectious Diseases and Clinical Microbiology at Ondokuz Mayis University Medical School in Turkey and working at Samsun Liv Hospital, Turkey. He is currently a Fellow of the European Society of Clinical Microbiology and Infectious Diseases (ESCMID), a founding member and Honorary Chief of ESCMID Study Group for Infections in Travelers and Migrants (ESGITM) and also a member of the Study Group for Viral Hepatitis (ESGVH). He has authored 162 publications in peer-reviewed international medical journals (H index is 31 in Web of Science), mainly in Crimean Congo hemorrhagic fever, viral hepatitis and healthcare associated infections. He has conducted workshops and courses in the area of effective communication, presentation skills, proposal and manuscript writing.
Tim McHugh, Editor-in-Chief
Professor McHugh leads the UCL Centre for Clinical Microbiology (CCM). Located at the Royal Free Hospital, CCM aims to improve the diagnosis and treatment of infectious diseases and contributes in the areas of antimicrobial resistance, infection in patients with immunosuppression and hospital acquired infection. Prof McHugh has a particular focus on respiratory infection and CCM has activities in all stages of the TB drug development pathway with projects on evaluation of new compounds as well as supporting the laboratory aspects of clinical trials. An underlying theme is the development of biomarkers of treatment outcome, whether transcriptomic analysis of in vitro treatments or the more complex picture of monitoring outcome in patients.
Speed
92 days to first decision for reviewed manuscripts only
37 days to first decision for all manuscripts
131 days from submission to acceptance
13 days from acceptance to publication
Citation Impact
2.924 - 2-year Impact Factor
3.032 - 5-year Impact Factor
1.367 - Source Normalized Impact per Paper (SNIP)
1.060 - SCImago Journal Rank (SJR)
Usage
356,195 Downloads
264 Altmetric Mentions
